These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 33967177)
41. Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings. Kawai N; Okubo S; Miyake K; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T Ann Nucl Med; 2010 Jun; 24(5):335-43. PubMed ID: 20379859 [TBL] [Abstract][Full Text] [Related]
42. Usefulness of dual isotope Osawa S; Tosaka M; Horiguchi K; Tokue A; Higuchi T; Tsushima Y; Yoshimoto Y Int J Clin Oncol; 2022 Aug; 27(8):1264-1272. PubMed ID: 35554754 [TBL] [Abstract][Full Text] [Related]
43. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach. Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238 [TBL] [Abstract][Full Text] [Related]
44. Role of FDG-PET/MRI, FDG-PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas. Hojjati M; Badve C; Garg V; Tatsuoka C; Rogers L; Sloan A; Faulhaber P; Ros PR; Wolansky LJ J Neuroimaging; 2018 Jan; 28(1):118-125. PubMed ID: 28718993 [TBL] [Abstract][Full Text] [Related]
45. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
46. Correlation Between Yu P; Lei J; Xu B; Wang R; Shen Z; Tian J Acad Radiol; 2020 May; 27(5):682-688. PubMed ID: 31311773 [TBL] [Abstract][Full Text] [Related]
47. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Musiek ES; Chen Y; Korczykowski M; Saboury B; Martinez PM; Reddin JS; Alavi A; Kimberg DY; Wolk DA; Julin P; Newberg AB; Arnold SE; Detre JA Alzheimers Dement; 2012 Jan; 8(1):51-9. PubMed ID: 22018493 [TBL] [Abstract][Full Text] [Related]
48. Arterial spin labeling versus Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403 [TBL] [Abstract][Full Text] [Related]
49. Lymph node standardized uptake values at pre-treatment Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776 [TBL] [Abstract][Full Text] [Related]
50. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma. Liu S; Fan X; Zhang C; Wang Z; Li S; Wang Y; Qiu X; Jiang T Eur Radiol; 2019 Mar; 29(3):1348-1354. PubMed ID: 30167811 [TBL] [Abstract][Full Text] [Related]
51. Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions. Nakayama M; Okizaki A; Ishitoya S; Sakaguchi M; Sato J; Aburano T Ann Nucl Med; 2013 Feb; 27(2):163-9. PubMed ID: 23188388 [TBL] [Abstract][Full Text] [Related]
52. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma. Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549 [TBL] [Abstract][Full Text] [Related]
53. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI. Kim Y; Cho HH; Kim ST; Park H; Nam D; Kong DS Neuroradiology; 2018 Dec; 60(12):1297-1305. PubMed ID: 30232517 [TBL] [Abstract][Full Text] [Related]
54. 18F-FDG PET/CT in primary brain lymphoma. Albano D; Bosio G; Bertoli M; Giubbini R; Bertagna F J Neurooncol; 2018 Feb; 136(3):577-583. PubMed ID: 29147860 [TBL] [Abstract][Full Text] [Related]
55. Multiple metabolic parameters and visual assessment of Ren Y; Liu J; Wang L; Luo Y; Ding X; Shi A; Liu J Abdom Radiol (NY); 2020 Nov; 45(11):3569-3580. PubMed ID: 32274551 [TBL] [Abstract][Full Text] [Related]
56. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma]. Li MG; Chen ZY; Liu G; Xiao HF; Chen XJ; Lou X; Ma L Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr; 40(2):146-150. PubMed ID: 29724302 [TBL] [Abstract][Full Text] [Related]
57. Classification of glioblastoma versus primary central nervous system lymphoma using convolutional neural networks. McAvoy M; Prieto PC; Kaczmarzyk JR; Fernández IS; McNulty J; Smith T; Yu KH; Gormley WB; Arnaout O Sci Rep; 2021 Jul; 11(1):15219. PubMed ID: 34312463 [TBL] [Abstract][Full Text] [Related]
58. Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation. Bhattacharjee R; Gupta M; Singh T; Sharma S; Khanna G; Parvaze SP; Patir R; Vaishya S; Ahlawat S; Singh A; Gupta RK Neuroradiology; 2022 Sep; 64(9):1801-1818. PubMed ID: 35435463 [TBL] [Abstract][Full Text] [Related]
59. Primary brain lymphoma and glioblastoma: evaluation of DCE T1 and DSC T2 MRI perfusion findings. Soydan H; Sözmen Cılız D; Cesur T; Tezgör Aksakal E Acta Radiol; 2024 Jul; 65(7):800-807. PubMed ID: 38798137 [TBL] [Abstract][Full Text] [Related]
60. [Correlation of ¹⁸F-FDG PET-CT maximum standard uptake value and T/N ratio with the prognosis of postoperative colorectal cancer]. Wang X; Peng G; Zhang X; Chen Z; Zhang B; Li Z Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Mar; 18(3):232-7. PubMed ID: 25809325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]